FORA Capital’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.61M | Buy |
+12,589
| New | +$1.61M | 0.18% | 145 |
|
2024
Q1 | – | Sell |
-24,306
| Closed | -$2.24M | – | 418 |
|
2023
Q4 | $2.24M | Buy |
+24,306
| New | +$2.24M | 0.19% | 144 |
|
2022
Q4 | – | Sell |
-3,185
| Closed | -$210K | – | 476 |
|
2022
Q3 | $210K | Buy |
+3,185
| New | +$210K | 0.04% | 381 |
|
2022
Q1 | – | Sell |
-2,773
| Closed | -$297K | – | 520 |
|
2021
Q4 | $297K | Buy |
+2,773
| New | +$297K | 0.12% | 226 |
|
2021
Q3 | – | Sell |
-715
| Closed | -$63K | – | 424 |
|
2021
Q2 | $63K | Buy |
+715
| New | +$63K | 0.01% | 678 |
|
2021
Q1 | – | Sell |
-4,185
| Closed | -$469K | – | 794 |
|
2020
Q4 | $469K | Buy |
4,185
+1,782
| +74% | +$200K | 0.07% | 300 |
|
2020
Q3 | $223K | Sell |
2,403
-237
| -9% | -$22K | 0.15% | 155 |
|
2020
Q2 | $206K | Buy |
+2,640
| New | +$206K | 0.07% | 331 |
|
2020
Q1 | – | Sell |
-848
| Closed | -$68K | – | 1052 |
|
2019
Q4 | $68K | Buy |
+848
| New | +$68K | 0.01% | 836 |
|